Periodic Reporting for period 1 - mfloDx (Adaptable Multiflow Diagnostic Platform to Genetically Identify Drug Resistant Infection)
Periodo di rendicontazione: 2019-12-01 al 2020-03-31
The aim of the project is to generate a feasibility report to determine the practical business and economic viability of the innovative mfloDx® platform in the largest TB diagnostic market, India. The objectives of the project were to establish supplier setup, certification and regulatory requirements, and possibilities for distribution; to run pricing models, expand IP, and to finalize business plan.